And the big uncertainty here, of course, around everything you're trying ... GameStop (GME) stock also rises following a CNBC report that outlines how the retailer is considering an investment ...

At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.

A Google Trends study published in the National Library of Medicine found a significant and growing public interest in GLP-1 agonists between 2023 and 2024. Researchers estimate roughly half of U ...

Share on Pinterest Scientists have found a link between certain eye conditions and GLP-1 medications. BONNINSTUDIO/Stocksy Past studies have found a potential link between semaglutide and the eye ...

After just a few years on the market, a new wave of GLP-1 drugs approved for weight loss have upended what we know about obesity. By now, these are household names: Mounjaro. Wegovy. Zepbound ...

“Our study confirms the increased likelihood of being diagnosed with what appears to be low-risk thyroid cancer after treatment with GLP-1 RAs — but not because patients treated with GLP-1 RAs ...

In a meta-analysis of nine randomized controlled trials, adults had an average lean mass loss of 2.5 kg with GLP-1 therapy. More research is needed to examine the implications of lean mass loss ...

Josh Gad is opening up about the weight loss success he’s had with GLP-1 medication — and sharing some of the conflicted feelings he’s had along the way. “I’m on a GLP-1 … this is the ...

And if you're not one for weights, or have other conditions preventing a new training regimen ... The discovery, of course, goes beyond those taking GLP-1 medications. And while the BCL6 discovery ...

Unfortunately, many patients may choose to forego additional treatments due to the dramatic increase in cost associated with brand name versus compounded GLP-1 drugs. 5. Q. Are any GLP-1s still on ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...